Published January 25, 2011
| Version v1
Patent
Open
Methods and compositions involving LcrV proteins
Creators
- 1. University of Chicago
- 2. Michigan State University
Contributors
Patent applicants:
Description
The present invention concerns methods and compositions involving modified LcrV proteins from Yersinia bacteria. These methods and compositions can be employed to invoke an immune response in a subject against the bacteria, while not suppressing the immune system as much as the native LcrV protein. In certain embodiments, the present invention relates to vaccines, as well as methods to protect a subject against Yersinia pestis and plague. Moreover, the present invention concerns methods and compositions for suppressing a subject's immune system using non-native LcrV polypeptides.
Files
US7875280.pdf
Files
(2.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:54d47caf4f3e6b7a16e865e65a1e70e3
|
2.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 29302405 A
- Patent number
- US 7875280 B2
- Other
- oai:uchicago.tind.io:8005
Dates
- Patent filed
-
2005-12-02